AIM IMMUNOTECH INC. Other Comprehensive Income (Loss), Net of Tax
AIM IMMUNOTECH INC. (AIM) reported Other Comprehensive Income (Loss), Net of Tax of -$12.33 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2015-11-16
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for the quarter ending 2015-09-30 was -$4.02M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for the quarter ending 2015-06-30 was -$4.98M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for the quarter ending 2015-03-31 was -$3.33M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for the quarter ending 2014-12-31 was -$4.50M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for fiscal 2014 was -$17.50M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for fiscal 2013 was -$16.30M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for fiscal 2012 was -$17.01M.
- AIM IMMUNOTECH INC. other comprehensive income (loss), net of tax for fiscal 2011 was -$8.43M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$4.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$9.00M derived: sum of 2 quarters · filed 2015-11-16 | -$12.33M 10-Q · filed 2015-11-16 | -$16.84M derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-06-30 | -$4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$8.32M 10-Q · filed 2015-08-12 | -$12.82M derived: sum of 3 quarters · filed 2015-08-12 | -$17.19M derived: sum of 4 quarters · filed 2015-08-12 |
| 2015-03-31 | -$3.33M 10-Q · filed 2015-05-12 | -$7.84M derived: sum of 2 quarters · filed 2015-05-12 | -$12.21M derived: sum of 3 quarters · filed 2015-05-12 | -$17.02M derived: sum of 4 quarters · filed 2015-05-12 |
| 2014-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$8.87M derived: sum of 2 quarters · filed 2015-03-19 | -$13.68M derived: sum of 3 quarters · filed 2015-03-19 | -$17.50M 10-K · filed 2015-03-19 |
| 2014-09-30 | -$4.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$9.18M derived: sum of 2 quarters · filed 2014-11-07 | -$12.99M 10-Q · filed 2014-11-07 | -$16.21M derived: sum of 4 quarters · filed 2015-03-19 |
| 2014-06-30 | -$4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$8.62M 10-Q · filed 2014-08-08 | -$11.84M derived: sum of 3 quarters · filed 2015-03-19 | -$15.98M derived: sum of 4 quarters · filed 2015-03-19 |
| 2014-03-31 | -$3.81M 10-Q · filed 2014-05-09 | -$7.03M derived: sum of 2 quarters · filed 2015-03-19 | -$11.17M derived: sum of 3 quarters · filed 2015-03-19 | -$16.54M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-12-31 | -$3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$7.36M derived: sum of 2 quarters · filed 2015-03-19 | -$12.72M derived: sum of 3 quarters · filed 2015-03-19 | -$16.30M 10-K · filed 2015-03-19 |
| 2013-09-30 | -$4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$9.50M derived: sum of 2 quarters · filed 2013-11-08 | -$13.08M 10-Q · filed 2013-11-08 | -$19.01M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-06-30 | -$5.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$8.94M 10-Q · filed 2013-08-09 | -$14.87M derived: sum of 3 quarters · filed 2015-03-19 | -$21.29M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-03-31 | -$3.58M 10-Q · filed 2013-05-08 | -$9.51M derived: sum of 2 quarters · filed 2015-03-19 | -$15.93M derived: sum of 3 quarters · filed 2015-03-19 | -$18.72M derived: sum of 4 quarters · filed 2015-03-19 |
| 2012-12-31 | -$5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$12.36M derived: sum of 2 quarters · filed 2015-03-19 | -$15.14M derived: sum of 3 quarters · filed 2015-03-19 | -$17.01M 10-K · filed 2015-03-19 |
| 2012-09-30 | -$6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$9.21M derived: sum of 2 quarters · filed 2012-11-02 | -$11.08M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$4.65M 10-Q · filed 2012-08-08 | ||
| 2012-03-31 | -$1.87M 10-Q · filed 2012-05-07 | |||
| 2011-12-31 | -$8.43M 10-K · filed 2014-03-14 | |||
| 2011-03-31 | -$407.00K 10-Q · filed 2012-05-07 | |||
| 2010-12-31 | -$14.11M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |